- prior exit: Pardes Biosciences
Opportunities
all opportunities ▸Internal company pages for screening and memo — not external source links.
No sourced opportunity yet — only GitHub / HN / PH / Devpost / arXiv / inbound ventures appear here (not career employers).
About
Co-founder and the Chief Medical Officer of Assembly Pharma (2012) and CMO/VP R&D for Assembly Biosciences (f\k\a Ventrus Bioscience), which reverse merged with Assembly Pharma in 2014. He helped ASMB raise > $300M to move 2 generations of novel HBV meds into Ph 1 and Ph 2 clinical studies. Uri has held roles at Schering Plough, Roche, and Gilead Science, and received medical training at UMDNJ, NYU and the NIH. Uri was a visiting partner at YC before he started Pardes to cure COVID-19
Activation — cold outreach, not cold investment
Generates a personal note referencing this founder's actual work, inviting a real application.
▸ Add / edit details
On save, the model re-reads scraped profile text plus your investor details, then rebuilds Experience / Education (adds and removes) and refreshes the score.
Reading scraped text + your details, rebuilding career facts, updating the score. Usually 15–40s.